REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,600 | +175.4% | 57,801 | +115.6% | 0.02% | +157.1% |
| Q1 2023 | $581 | +2.5% | 26,811 | +12.6% | 0.01% | 0.0% |
| Q4 2022 | $567 | -99.9% | 23,804 | -0.7% | 0.01% | +16.7% |
| Q3 2022 | $473,000 | -37.2% | 23,969 | -38.0% | 0.01% | -25.0% |
| Q2 2022 | $753,000 | +325.4% | 38,632 | +456.5% | 0.01% | +700.0% |
| Q1 2022 | $177,000 | +50.0% | 6,942 | +48.0% | 0.00% | 0.0% |
| Q4 2021 | $118,000 | -90.7% | 4,691 | -89.8% | 0.00% | -83.3% |
| Q3 2021 | $1,271,000 | +182.4% | 46,205 | +370.9% | 0.01% | +200.0% |
| Q1 2021 | $450,000 | +54.6% | 9,813 | +17.3% | 0.00% | 0.0% |
| Q3 2020 | $291,000 | -60.4% | 8,365 | -64.0% | 0.00% | -66.7% |
| Q2 2020 | $735,000 | +574.3% | 23,266 | +366.8% | 0.01% | +500.0% |
| Q1 2020 | $109,000 | – | 4,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |